Human CD109 Biotinylated Antibody

Catalog #: BAF4385 Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
BAF4385

All CD109 Antibodies

Product Details

Supplemental Products

Reviews

Summary Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Human CD109 Biotinylated Antibody Summary

Species Reactivity

Human

Specificity

Detects human CD109 in Western blots.

Source

Polyclonal Sheep IgG

Purification

Antigen Affinity-purified

Immunogen

Mouse myeloma cell line NS0-derived recombinant human CD109
Val22-Ser1268 (Tyr703Ser)
Accession # AAL84159

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.

Label

Biotin

Applications

Recommended Concentration

Sample

Western Blot

0.1 µg/mL

Recombinant Human CD109 (Catalog # 4385-CD)

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Reconstitution Calculator

Preparation and Storage

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS.

Shipping

The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: CD109

CD109 is a GPI-anchored member of the alpha-2-macroglobulin (A2M) and complement family of proteins (1). Mature human CD109 contains a bait region with recognition sequences for multiple proteases, an internal thioester bond, and a domain similar to the receptor binding domain of A2M (2). Cleavage of A2M family proteins within the bait region activates the thioester bond to promote covalent bonding to nucleophilic groups in adjacent molecules (3, 4). Within the region included in this recombinant protein, human CD109 shares 71-73% amino acid (aa) sequence identity with mouse and rat CD109. It shares 27-33% aa sequence identity with A2M and complement factors C3, C4, and C5. Alternate splicing of human CD109 generates two isoforms with short deletions and one that is truncated within the bait region. CD109 is expressed on activated T cells and platelets, hematopoietic stem cells, megakaryocyte precursors, vascular endothelial cells, basal and myoepithelial cells of secretory glands, and squamous cell carcinomas (2, 5-9). It is produced as a 170-180 kDa glycoprotein that is autocatalytically processed to 150 kDa and 120 kDa forms (2, 6, 10). CD109 on keratinocytes binds TGF-beta and associates with TGF-beta RI and TGF-beta RII, resulting in inhibition of TGF-beta signaling (11). Polymorphisms of CD109 include the platelet-specific Gov antigen and the blood group ABH antigens (12, 13). Alloantibodies directed against these antigens result in unsuccessful platelet transfusions, neonatal alloimmune thrombocytopenia, and posttransfusion purpura (14).

References

Travis, J. and G.S. Salvesen (1983) Annu. Rev. Biochem. 52:655.
Lin, M. et al. (2002) Blood 99:1683.
Christensen, U. and L. Sottrup-Jensen (1984) Biochemistry 23:6619.
Wallis, R. et al. (2007) J. Biol. Chem. 282:7844.
Murray, L.J. et al. (1999) Exp. Hematol. 27:1282.
Haregewoin, A. et al. (1994) Cell. Immunol. 156:357.
Hasegawa, M. et al. (2007) Pathol. Int. 57:245.
Brashem-Stein, C. et al. (1988) J. Immunol. 140:2330.
Hashimoto, M. et al. (2004) Oncogene 23:3716.
Solomon, K.R. et al. (2004) Gene 327:171.
Finnson, K.W. et al. (2006) FASEB J. 20:1525.
Schuh, A.C. et al. (2002) Blood 99:1692.
Kelton, J.G. et al. (1998) J. Lab. Clin. Med. 132:142.
Rozman, P. (2002) Transpl. Immunol. 10:165.

Entrez Gene IDs

135228 (Human); 235505 (Mouse); 363104 (Rat)

Alternate Names

150 kDa TGF-beta-1-binding protein; activated T-cell marker CD109; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7; CD109 antigen (Gov platelet alloantigens); CD109 antigen; CD109 molecule; CD109; CPAMD7; CPAMD7r150; DKFZp762L1111; FLJ38569; FLJ41966; Gov platelet alloantigens; p180; Platelet-specific Gov antigen; RP11-525G3.1